Published in Vaccine on July 16, 2013
Microbiology laboratory and the management of mother-child varicella-zoster virus infection. World J Virol (2016) 0.75
Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs. Vaccines (Basel) (2015) 0.75
Varicella. Lancet (2006) 4.47
Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect (2000) 1.95
Economic evaluations of varicella vaccination programmes: a review of the literature. Pharmacoeconomics (2003) 1.85
The utility of serologic testing for varicella in an adolescent population. Vaccine (2001) 1.47
Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiol Infect (2004) 1.26
Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol (1994) 1.20
Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bull Math Biol (1999) 1.14
Cost-effectiveness of varicella vaccination programs: an update of the literature. Expert Rev Vaccines (2008) 1.10
Seroepidemiology of varicella and the reliability of a self-reported history of varicella infection in Singapore military recruits. Ann Acad Med Singapore (2007) 0.96
Comparison of varicella history with presence of varicella antibody in refugees. Vaccine (2004) 0.95
Maternal varicella history as a predictor of varicella immune status. J Perinatol (1997) 0.94
The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK. Epidemiol Infect (2007) 0.93
Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys. Vaccine (2008) 0.91
Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection. J Virol Methods (2009) 0.89
Seroprevalence of varicella antibodies in healthcare workers and health sciences students. Reliability of self-reported history of varicella. Vaccine (2005) 0.88
Predictive value of personal recall of chicken pox infection: implications for the use of varicella vaccine. Med J Aust (2001) 0.88
Screening healthcare workers for varicella-zoster virus: can we trust the history? Infect Control Hosp Epidemiol (2004) 0.87
Age-specific rates of serological immunity in patients with a negative history for varicella infection. Infect Control Hosp Epidemiol (1998) 0.87
Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults. Paediatr Perinat Epidemiol (2011) 0.86
Self-reported history of vaccination and disease and immunity against hepatitis A, hepatitis B, tetanus, diphtheria and varicella among Spanish military recruits. Hum Vaccin (2010) 0.84
Reliability of varicella history in children and adolescents. Swiss Med Wkly (2005) 0.83
Validity of self-reported varicella disease history in pregnant women attending prenatal clinics. Public Health Rep (2007) 0.83
How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age. Int J Infect Dis (2003) 0.81
Reported exposure to chickenpox: a predictor of positive anti-varicella-zoster antibodies in parturient women. Fetal Diagn Ther (2001) 0.81
Seroprevalence of varicella among children and adolescents in Valencia, Spain. Reliability of the parent's reported history and the medical file for identification of potential candidates for vaccination. Hum Vaccin (2005) 0.81
Presumptive varicella vaccination is warranted in Greek adolescents lacking a history of disease or household exposure. Eur J Pediatr (2008) 0.81
Identification of potential candidates for varicella vaccination by history: questionnaire and seroprevalence study. BMJ (2004) 0.77